Cargando…
Projection of budgetary savings to US state Medicaid programs from reduced nursing home use due to an Alzheimer's disease treatment
INTRODUCTION: The approval of a disease‐modifying Alzheimer's disease (AD) treatment could provide relief to US state budgets that were hit hard by the COVID‐19 pandemic, as mostly Medicare would cover treatment cost, whereas Medicaid would see savings from reduced nursing home use. METHODS: We...
Autores principales: | Lam, Jenny, Jun, Hankyung, Cho, Sang Kyu, Hanson, Mark, Mattke, Soeren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968122/ https://www.ncbi.nlm.nih.gov/pubmed/33748394 http://dx.doi.org/10.1002/dad2.12159 |
Ejemplares similares
-
Alzheimer's biomarkers in daily practice (ABIDE) project: Rationale and design
por: de Wilde, Arno, et al.
Publicado: (2017) -
Trends in health service use and potentially avoidable hospitalizations before Alzheimer's disease diagnosis: A matched, retrospective study of US Medicare beneficiaries
por: Desai, Urvi, et al.
Publicado: (2019) -
Alzheimer's disease severity, objectively determined and measured
por: Gross, Alden L., et al.
Publicado: (2016) -
Prognostic value of ATN Alzheimer biomarkers: 60‐month follow‐up results from the Argentine Alzheimer's Disease Neuroimaging Initiative
por: Allegri, Ricardo F., et al.
Publicado: (2020) -
Clinician-patient communication during the diagnostic workup: The ABIDE project
por: Visser, Leonie N.C., et al.
Publicado: (2019)